PV Bulletin

Topic

Pharmacovigilance

Pharmacovigilance covers the full lifecycle of detecting, assessing, and preventing adverse effects of medicines. Browse verified PV Bulletin updates across signal management, labeling, inspections, country compliance, and QPPV oversight — written for operational drug safety teams, not generic pharma news.

1 matching update · Sorted by impact priority

publicFDA · USA · Updated Jun 4, 2026

FDA Final Guidance on Postapproval Requirements and Resources for ANDAs

Urgency: Low

Review the guidance to ensure compliance with post-marketing safety reporting timelines and annual report submissions; update SOPs for ICSR processing and periodic report generation.

Country ComplianceICSRRegulatory Intelligence Lead
SOP Impact3 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Labeling Lead, QPPV
verifiedRegulatory action: Guideline
Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only

Pharmacovigilance Updates & Drug Safety Intelligence | PV Bulletin